Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin Effects on Platelet Proteome (LovaC)
NCT02389868Phase 2Completed
- Sponsor
- Université de Sherbrooke
- Start
- Feb 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lovastatin in hypercholesterolemia, sponsored by Université de Sherbrooke. Primary endpoint: Change in Signal Intensity Measured for Each Protein Identified by Mass Spectrometry in Blood Platelets Lysates at 6 weeks. Started Feb 2015; status: completed.
02
Drugs
lovastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02389868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389868.